Next Article in Journal
Acute Promyelocytic Leukemia in the Real World: Understanding Outcome Differences and How We Can Improve Them
Next Article in Special Issue
Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan
Previous Article in Journal
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Previous Article in Special Issue
Daratumumab during Myeloma Induction Therapy Is Associated with Impaired Stem Cell Mobilization and Prolonged Post-Transplant Hematologic Recovery
 
 
Article

Article Versions Notes

Cancers 2024, 16(23), 4090; https://doi.org/10.3390/cancers16234090
Action Date Notes Link
article xml file uploaded 6 December 2024 10:30 CET Original file -
article xml uploaded. 6 December 2024 10:30 CET Update https://www.mdpi.com/2072-6694/16/23/4090/xml
article pdf uploaded. 6 December 2024 10:30 CET Version of Record https://www.mdpi.com/2072-6694/16/23/4090/pdf
article supplementary file uploaded. 6 December 2024 10:30 CET - https://www.mdpi.com/2072-6694/16/23/4090#supplementary
article html file updated 6 December 2024 10:34 CET Original file https://www.mdpi.com/2072-6694/16/23/4090/html
Back to TopTop